Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Methotrexate embryopathy after exposure to low weekly doses in early pregnancy.

Martín MC, Barbero P, Groisman B, Aguirre MÁ, Koren G.

Reprod Toxicol. 2014 Jan;43:26-9.

PMID:
24513926
2.

Pregnancy outcome after methotrexate treatment for rheumatic disease prior to or during early pregnancy: a prospective multicenter cohort study.

Weber-Schoendorfer C, Chambers C, Wacker E, Beghin D, Bernard N; Network of French Pharmacovigilance Centers, Shechtman S, Johnson D, Cuppers-Maarschalkerweerd B, Pistelli A, Clementi M, Winterfeld U, Eleftheriou G, Pupco A, Kao K, Malm H, Elefant E, Koren G, Vial T, Ornoy A, Meister R, Schaefer C.

Arthritis Rheumatol. 2014 May;66(5):1101-10. doi: 10.1002/art.38368.

3.

No evidence for an increased risk of adverse pregnancy outcome after paternal low-dose methotrexate: an observational cohort study.

Weber-Schoendorfer C, Hoeltzenbein M, Wacker E, Meister R, Schaefer C.

Rheumatology (Oxford). 2014 Apr;53(4):757-63. doi: 10.1093/rheumatology/ket390. Epub 2013 Dec 24.

PMID:
24369411
4.

Low dose weekly methotrexate in early pregnancy. A case series and review of the literature.

Ostensen M, Hartmann H, Salvesen K.

J Rheumatol. 2000 Aug;27(8):1872-5. Review.

PMID:
10955326
5.
6.

Use of methotrexate in young patients with respect to the reproductive system.

Gromnica-Ihle E, Krüger K.

Clin Exp Rheumatol. 2010 Sep-Oct;28(5 Suppl 61):S80-4. Epub 2010 Oct 28. Review.

PMID:
21044438
7.

Adult and two children with fetal methotrexate syndrome.

Bawle EV, Conard JV, Weiss L.

Teratology. 1998 Feb;57(2):51-5.

PMID:
9562676
8.

Multiple congenital anomalies associated with weekly low-dose methotrexate treatment of the mother.

Buckley LM, Bullaboy CA, Leichtman L, Marquez M.

Arthritis Rheum. 1997 May;40(5):971-3.

PMID:
9153561
9.

Multiple anomalies in a fetus exposed to low-dose methotrexate in the first trimester.

Nguyen C, Duhl AJ, Escallon CS, Blakemore KJ.

Obstet Gynecol. 2002 Apr;99(4):599-602.

PMID:
12039119
10.
11.

Teratogen update: methotrexate.

Hyoun SC, Običan SG, Scialli AR.

Birth Defects Res A Clin Mol Teratol. 2012 Apr;94(4):187-207. doi: 10.1002/bdra.23003. Epub 2012 Mar 20. Review.

PMID:
22434686
12.

Low-dose and high-dose methotrexate are two different drugs in practical terms.

Malaviya AN, Sharma A, Agarwal D, Kapoor S, Garg S, Sawhney S.

Int J Rheum Dis. 2010 Oct;13(4):288-93. doi: 10.1111/j.1756-185X.2010.01564.x. Epub 2010 Aug 16.

PMID:
21199463
13.

Importance of timing of gestational exposure to methotrexate for its teratogenic effects when used in setting of misdiagnosis of ectopic pregnancy.

Poggi SH, Ghidini A.

Fertil Steril. 2011 Sep;96(3):669-71. doi: 10.1016/j.fertnstert.2011.06.014. Epub 2011 Jul 5.

PMID:
21733506
14.

Therapy with immunosuppressive drugs and biological agents and use of contraception in patients with rheumatic disease.

Østensen M, von Esebeck M, Villiger PM.

J Rheumatol. 2007 Jun;34(6):1266-9. Epub 2007 May 15.

PMID:
17516615
15.

Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.

Shea B, Swinden MV, Tanjong Ghogomu E, Ortiz Z, Katchamart W, Rader T, Bombardier C, Wells GA, Tugwell P.

Cochrane Database Syst Rev. 2013 May 31;5:CD000951. doi: 10.1002/14651858.CD000951.pub2. Review.

PMID:
23728635
16.

Mechanisms of action of methotrexate.

Chan ES, Cronstein BN.

Bull Hosp Jt Dis (2013). 2013;71 Suppl 1:S5-8. Review.

17.

Outcomes after anti-rheumatic drug use before and during pregnancy: a cohort study among 150,000 pregnant women and expectant fathers.

Viktil KK, Engeland A, Furu K.

Scand J Rheumatol. 2012 May;41(3):196-201. doi: 10.3109/03009742.2011.626442. Epub 2012 Mar 9.

PMID:
22401133
18.

Anti-TNF therapies and pregnancy: outcome of 130 pregnancies in the British Society for Rheumatology Biologics Register.

Verstappen SM, King Y, Watson KD, Symmons DP, Hyrich KL; BSRBR Control Centre Consortium, BSR Biologics Register.

Ann Rheum Dis. 2011 May;70(5):823-6. doi: 10.1136/ard.2010.140822. Epub 2011 Feb 28.

19.

Adverse events in methotrexate-treated rheumatoid arthritis patients.

Sandoval DM, Alarcón GS, Morgan SL.

Br J Rheumatol. 1995 Nov;34 Suppl 2:49-56. Review.

PMID:
8535650
20.

[Current "off label use" of methotrexate for chronic inflammatory rheumatic diseases].

Briem S, Lorenz HM.

Z Rheumatol. 2011 Feb;70(2):123-8. doi: 10.1007/s00393-010-0685-2. German.

PMID:
21267732
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk